Inhibition of mesothelioma cancer stem‐like cells with adenovirus‐mediated NK4 gene therapy
Authors:
Open Access
- 10 December 2014
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 137 (2) , 481-490
Abstract
Malignant mesothelioma (MM) is a highly invasive and chemoresistant malignancy induced by asbestos fibers. NK4, a hepatocyte growth factor antagonist and angiogenesis inhibitor, consists of the N‐terminal hairpin domain and four kringle domains of the α‐chain of hepatocyte growth factor. The therapeutic potential of NK4 has been demonstrated in a variety of tumor types. However, the mechanisms by which NK4 inhibits tumor growth have not been well delineated. In this study, it is shown that the NK4 adenovirus (Ad‐NK4) potently inhibits cell viability, invasiveness and tumorigenicity of human MM cells. Significantly, this study demonstrates for the first time that Ad‐NK4 inhibits cancer stem‐like cell (CSC) properties as assessed by spheroid formation assay, side population analysis and flow cytometric sorting of CD24 cells. In addition to inhibiting phosphorylation of Met and AKT, Ad‐NK4 markedly suppressed the active form of β‐catenin, a key mediator of both Wnt and AKT pathways. It is further demonstrated that expression of NK4 suppresses β‐catenin nuclear localization and transcriptional activity. Intriguingly, the expression levels of Oct4 and Myc, two critical stem cell factors and downstream targets of β‐catenin, were also diminished by Ad‐NK4. Furthermore, the strong antitumor effect of NK4 was found to be linked to its ability to inhibit CSCs as revealed by immunohistochemical examination of tumor specimens from a mouse xenograft model of human MM. These findings suggest that NK4 acts as a CSC inhibitor by impeding Met/AKT/β‐catenin signaling and holds promise for achieving durable therapeutic responses in MM by constraining the CSC component of these aggressive tumors.Keywords
Funding Information
- Mesothelioma Applied Research Foundation
- National Basic Research Program of China (2010CB529401)
- Natural Science Foundation of China (81072205)
- NCI (CA-114047)
This publication has 50 references indexed in Scilit:
- The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancerCell Death & Disease, 2013
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotypeProceedings of the National Academy of Sciences, 2011
- β-Catenin Enhances Oct-4 Activity and Reinforces Pluripotency through a TCF-Independent MechanismCell Stem Cell, 2011
- Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleosteminProceedings of the National Academy of Sciences, 2009
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 AssociationJournal of Biological Chemistry, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- A protein interaction network for pluripotency of embryonic stem cellsNature, 2006
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- Tumour-cell invasion and migration: diversity and escape mechanismsNature Reviews Cancer, 2003